Cardiac expression of the Na+/Ca2+ exchanger NCX1 is highly dependent on GATA-4 binding to specific promoter sites.
Answers are grounded in this paper and cite their sources.
GATA-4 binding critically drives cardiac NCX1 expression; leaves open its role in human disease and therapeutic targeting.
The cardiac sarcolemmal Na(+)/Ca(2+) exchanger plays a primary role in Ca(2+) efflux and is important in regulating intracellular Ca(2+) and beat-to-beat contractility. Of the three Na(+)/Ca(2+) exchanger genes cloned (NCX1, NCX2, and NCX3), only NCX1 is expressed in cardiac myocytes. NCX1 has alternative promoters for heart, kidney, and brain tissue-specific transcripts. Analysis of the cardiac NCX1 promoter (at -336 bp) identified a cardiac-specific minimum promoter (at -137) and two GATA sites (at -75 and -145). In this study, gel shift and supershift analyses identified GATA-4 in primary neonatal cardiac myocytes. Site-directed mutagenesis of the GATA-4 site at -75 abolishes binding and reduces activity of the minimum and full-length promoters by >90 and approximately 60%, respectively. Mutation of the GATA site at -145 reduces activity of the full-length promoter by approximately 30%. Mutation of an E-box at -175 does not alter promoter activity.
No takes yet. Share an insight, caveat, or question.
Nicholas et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: